Riskpilot← Back to searchSign inGet full accessNORDIC TRADE PARTNER AS
ASActiveOrg 925174408Dammyr 3, 1605 FredrikstadWholesale of pharmaceutical and medical goods · NACE 4646Est. 20200 employees
Revenue 2025
NOK 0
EBITDA margin
—
-905% vs 2024
Equity ratio
90.0%
Financial strength
Net profit 2025
NOK -51K
-352% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -63K | -905% |
| Net profit | NOK -51K | -352% |
| Total assets | NOK 122K | -81% |
| Equity | NOK 110K | -83% |
| Employees | 0 | — |
Legal name
NORDIC TRADE PARTNER AS
Org number
925174408
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
9. juni 2020
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Trading, kjøp og salg av alle typer varer som industrielle materialer og ferdige varer, samt medisinske vernevarer og distribusjon av medisinsk utstyr. Herunder import og eksport. Investering i eiendommer samt deltakelse i andre selskaper i norge og internationalt.
Address
Dammyr 3, 1605 Fredrikstad
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6 | 5 438 | 105 | 22 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −60 | 458 | −115 | 8 | −63 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −60 | 458 | −115 | 8 | −63 |
| Net financials | 0 | 0 | 10 | 12 | 12 |
| Profit before tax | −60 | 458 | −104 | 20 | −51 |
| Tax | −13 | 101 | 0 | −0 | −0 |
| Net profit | −47 | 357 | −104 | 20 | −51 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 273 | 1 080 | 724 | 640 | 122 |
| Equity | 366 | 724 | 619 | 640 | 110 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 907 | 356 | 105 | 0 | 12 |
| Total debt | 907 | 356 | 105 | 0 | 12 |
EBITDA margin
-6283300.0%
This company
15.8%
Market median
-39767822% vs market
20212025
Equity ratio
90.0%
This company
38.2%
Market median
+136% vs market
20212025
Return on equity
-46.5%
This company
18.4%
Market median
-353% vs market
20212025
Net profit margin
-5105800.0%
This company
8.1%
Market median
-63034668% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JD Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JD | Chairman | 2022 |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 51% | 51% | 2022 | |
| Company | 49% | 49% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Da Investing Co As
NORDIC TRADE PARTNER AS Board members of NORDIC TRADE PARTNER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Junfeng Dai | Chief Executive Officer | 0 companies |
| Jian Da | Chairman | 0 companies |